•
Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L: All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood. 1990 Nov 1;76(9):1704-9. Pubmed•
Mao JT, Goldin JG, Dermand J, Ibrahim G, Brown MS, Emerick A, McNitt-Gray MF, Gjertson DW, Estrada F, Tashkin DP, Roth MD: A pilot study of all-trans-retinoic acid for the treatment of human emphysema. Am J Respir Crit Care Med. 2002 Mar 1;165(5):718-23. Pubmed•
Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ, Wang ZY: Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 1988 Aug;72(2):567-72. Pubmed•
Sanz MA: Treatment of acute promyelocytic leukemia. Hematology Am Soc Hematol Educ Program. 2006;:147-55. Pubmed•
Roth MD, Connett JE, D'Armiento JM, Foronjy RF, Friedman PJ, Goldin JG, Louis TA, Mao JT, Muindi JR, O'Connor GT, Ramsdell JW, Ries AL, Scharf SM, Schluger NW, Sciurba FC, Skeans MA, Walter RE, Wendt CH, Wise RA: Feasibility of retinoids for the treatment of emphysema study. Chest. 2006 Nov;130(5):1334-45. Pubmed•
Tirado Sanchez A, Leon Dorantes G: [Erectile dysfunction during isotretinoin therapy] Actas Urol Esp. 2005 Nov-Dec;29(10):974-6. Pubmed•
Berard A, Azoulay L, Koren G, Blais L, Perreault S, Oraichi D: Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective. Br J Clin Pharmacol. 2007 Feb;63(2):196-205. Pubmed•
Amichai B, Shemer A, Grunwald MH: Low-dose isotretinoin in the treatment of acne vulgaris. J Am Acad Dermatol. 2006 Apr;54(4):644-6. Pubmed•
Holmes SC, Bankowska U, Mackie RM: The prescription of isotretinoin to women: is every precaution taken? Br J Dermatol. 1998 Mar;138(3):450-5. Pubmed•
Seukeran DC, Cunliffe WJ: Acne vulgaris in the elderly: the response to low-dose isotretinoin. Br J Dermatol. 1998 Jul;139(1):99-101. Pubmed• http://en.wikipedia.org/wiki/Isotretinoin
• http://en.wikipedia.org/wiki/Tretinoin
• Cheskis, B. and Freedman, L.P., Mol. Cell. Biol., 14: 3329, (1994).
• Cancer Res. , 40 : 214, (1980).
• Horst, R.L. et al.: Biochemistry, 34, 1203 (1998)
• Nagase, S.: Gidu Gaig. Igak. Kiyo, 47, 25 (1998)
• Tzimas, G. et al.: Drug Metab. Disp., 22, 928 (1998)
• Okuno, M. et al.: Kanxo, 39, 224 (1998)
• Carter, H.E., et al.: J. Biol. Chem., 175, 683 (1943)
• Munoz-Botella, S., et al.: J. Pharm. Biomed. Anal., 14, 909 (1996)
• Proksa, B., et al.: Anal. Chim. Acta, 434, 75 (1996)
• Gan, J., et al.: Chem. Res. Toxicol., 22, 690 (2008)
• Chen, P., et al.: Toxicol. App. Pharmacol.,
• Lerche, C., et al.: Exp. Dermatol., 17, 972 (2008)
• Sato, T., et al.: J. Med. Chem., 51, 7705 (2008)
• Macejova, D., et al.: Toxicol. Lett., 184, 114 (2008)
• Kamm, J.J., et al.: J. Am. Acad. Dermatol., 6, 652 (1982)
• Sasai, Y., et al.: J. Neurol., 249, 41 (1982)
• Warrel, R.P., et al.: Leukemia, 8, 929 (1982)